103 Participants Needed

Stent Placement After Ureteroscopy for Kidney Stones

Recruiting at 8 trial locations
RH
Overseen ByRyan Hsi, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Vanderbilt University Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 5 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The rationale for this study is to determine if there is a difference in complications among patients undergoing ureteroscopy for renal stones who receive a stent compared to not receiving a stent postoperatively.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Ureteroscopy for kidney stones?

Research shows that ureteroscopy, including both flexible and semi-rigid types, is effective for managing kidney stones, with success rates of up to 90% for smaller stones. It is a reliable and minimally invasive method for treating stones in the urinary tract.12345

Is stent placement after ureteroscopy for kidney stones safe?

Ureteroscopy, including flexible and retrograde approaches, is generally considered safe for treating kidney stones, with most complications being mild. In a large study, complications occurred in 18.9% of procedures, mostly mild, with some related to infection. Another study found minimal complications in transplant patients, indicating the procedure's safety.678910

How does the treatment of ureteroscopy for kidney stones differ from other treatments?

Ureteroscopy is a unique treatment for kidney stones because it involves using a small scope inserted through the urethra and bladder to directly access and remove stones from the ureter or kidney, often without the need for an incision. Unlike other treatments, it can be performed with or without the placement of a ureteral stent (a small tube to keep the ureter open), which is debated for its necessity in uncomplicated cases.1112131415

Research Team

RH

Ryan Hsi, MD

Principal Investigator

Vanderbilt University Medical Center

Eligibility Criteria

This trial is for adults with nonobstructing kidney stones smaller than 1.5cm in total diameter who are undergoing ureteroscopy. It's not for those under 18, pregnant, planning multiple surgeries, or with certain kidney conditions like a solitary kidney or reduced function (eGFR <60 mL/min).

Inclusion Criteria

I have a kidney stone smaller than 1.5cm and am getting a ureteroscopy.

Exclusion Criteria

I have one kidney or my kidney function is reduced.
I am under 18 years old.
I have a kidney stone in my ureter.
See 5 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo ureteroscopy for renal stones, with or without ureteral stent placement

1 day
1 visit (in-person)

Follow-up

Participants are monitored for complications and quality of life post-ureteroscopy

4-8 weeks
2 visits (in-person)

Extended Follow-up

Participants are assessed for long-term complications and quality of life impacts

30 days

Treatment Details

Interventions

  • Ureteroscopy
Trial OverviewThe study aims to see if there's a difference in complications when patients receive a stent after ureteroscopy for kidney stones versus not receiving one at all.
Participant Groups
2Treatment groups
Active Control
Group I: Ureteral stent groupActive Control1 Intervention
A ureteral stent will be placed after ureteroscopy.
Group II: No ureteral stent groupActive Control1 Intervention
A ureteral stent will not be placed after ureteroscopy.

Ureteroscopy is already approved in European Union, United States, Canada, Japan for the following indications:

🇪🇺
Approved in European Union as Ureteroscopy for:
  • Renal calculi
  • Ureteral calculi
  • Upper urinary tract calculi
  • Nephrolithiasis
  • Ureteral obstruction
🇺🇸
Approved in United States as Ureteroscopy for:
  • Kidney stones
  • Ureteral stones
  • Urinary tract obstruction
  • Hematuria
  • Ureteral tumors
🇨🇦
Approved in Canada as Ureteroscopy for:
  • Renal calculi
  • Ureteral calculi
  • Upper urinary tract calculi
  • Nephrolithiasis
  • Ureteral obstruction
🇯🇵
Approved in Japan as Ureteroscopy for:
  • Kidney stones
  • Ureteral stones
  • Urinary tract obstruction
  • Hematuria
  • Ureteral tumors

Find a Clinic Near You

Who Is Running the Clinical Trial?

Vanderbilt University Medical Center

Lead Sponsor

Trials
922
Recruited
939,000+

University of California, Los Angeles

Collaborator

Trials
1,594
Recruited
10,430,000+

Brigham and Women's Hospital

Collaborator

Trials
1,694
Recruited
14,790,000+

Penn State Health

Collaborator

Trials
2
Recruited
1,200+

Université de Montréal

Collaborator

Trials
223
Recruited
104,000+

University of California, Davis

Collaborator

Trials
958
Recruited
4,816,000+

University of California, San Diego

Collaborator

Trials
1,215
Recruited
1,593,000+

Indiana University

Collaborator

Trials
1,063
Recruited
1,182,000+

Findings from Research

Percutaneous nephrolithotomy (PCNL) has a higher initial stone-free rate for treating intermediate-size renal stones (2-3 cm) compared to retrograde flexible ureteroscopy (FURS), but FURS can achieve comparable final stone-free rates after additional treatments.
PCNL is associated with a higher rate of intraoperative complications and longer hospital stays, while FURS presents a safer alternative with fewer complications, making it a viable option for patients.
Comparison of retrograde flexible ureteroscopy and percutaneous nephrolithotomy in treating intermediatesize renal stones (2-3cm): a meta-analysis and systematic review.Zewu, Z., Cui, Y., Feng, Z., et al.[2020]
The study evaluated the learning curve for performing semi-rigid ureterorenolithotripsy in 60 procedures on patients with ureterolithiasis up to 1 cm, revealing significant improvements in surgical performance after the first 40 cases.
After completing 40 procedures, there was minimal further improvement in both the quality and efficiency of the surgery, indicating that this is the minimum number of cases needed to safely perform the procedure.
Learning curve of semi-rigid ureteroscopy for small calculi: how many cases are necessary?Ilias, D., Passerotti, CC., Pontes Junior, J., et al.[2023]
In a study of 789 patients with ureter calculi and asymptomatic renal calculi under 15 mm, ureteroscopy (URS) showed a higher stone-free rate (97.3%) compared to shockwave lithotripsy (SWL) (93.9%).
URS also resulted in better long-term outcomes, with a 2-year intervention-free survival rate of 88.1% and stone-event-free survival of 80.1%, compared to 84.2% and 71.0% for SWL, respectively.
Decreased Recurrence of Urolithiasis After Simultaneous Ureteroscopic Surgery for Ureter and Ipsilateral Renal Calculi: Comparison to Shockwave Lithotripsy for Ureter Calculi Alone.Ito, K., Takahashi, T., Kanno, T., et al.[2022]

References

Comparison of retrograde flexible ureteroscopy and percutaneous nephrolithotomy in treating intermediatesize renal stones (2-3cm): a meta-analysis and systematic review. [2020]
Learning curve of semi-rigid ureteroscopy for small calculi: how many cases are necessary? [2023]
Decreased Recurrence of Urolithiasis After Simultaneous Ureteroscopic Surgery for Ureter and Ipsilateral Renal Calculi: Comparison to Shockwave Lithotripsy for Ureter Calculi Alone. [2022]
[Diagnostic and therapeutic advantages of rigid ureteroscopy: retrospective study of 304 cases]. [2019]
Redefining the limits of flexible ureterorenoscopy. [2022]
The study of double-J stent free mode of flexible ureteroscopy and laser lithotripsy: a single centre experience. [2023]
Complications of ureteroscopy for stone disease. [2017]
Morbidity of Retrograde Flexible Ureteral Approach for Pyelo-Caliceal Stones - A Retrospective Review of 4500 Procedures. [2020]
Flexible Ureteroscopy as the New Standard for the Management of Renal Transplant Urolithiasis [2021]
Improved effectiveness and safety of flexible ureteroscopy for renal calculi ( [2020]
11.United Statespubmed.ncbi.nlm.nih.gov
Routine stenting after ureteroscopy for distal ureteral calculi is unnecessary: results of a randomized controlled trial. [2022]
12.United Statespubmed.ncbi.nlm.nih.gov
Prestenting improves ureteroscopic stone-free rates. [2022]
13.United Statespubmed.ncbi.nlm.nih.gov
The results of ureteral stenting after ureteroscopic lithotripsy for ureteral calculi: a systematic review and meta-analysis. [2022]
14.United Statespubmed.ncbi.nlm.nih.gov
Placement of ureteral stent after uncomplicated ureteroscopy: do we really need it? [2022]
Stenting versus non-stenting following uncomplicated ureteroscopic lithotripsy: Comparsion and evaluation of symptoms. [2018]